Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Kim

Showing results (61-70 of 226) with videos related to

Pageof 23
Sort By:
The Journal of Biological Chemistry|April 3, 2003
The human organic anion transport protein SLC21A6 is not sufficient for bilirubin transportPijun Wang, Richard B Kim, J Roy Chowdhury, et al.
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|June 13, 2013
Sildenafil and furosemide associated ototoxicity: consideration of drug-drug interactions, synergy, and broader clinical relevanceLeslie Skeith, Cory Yamashita, Sanjay Mehta, et al.
British Journal of Clinical Pharmacology|March 18, 2025
Severe myelosuppression and alopecia after thiopurine initiation in a patient with NUDT15 deficiencyAnnie Siyu Wu, Lee Mozessohn, Richard B Kim, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 20, 2002
The anthelminthic agent albendazole does not interact with p-glycoproteinGracia Merino, Ana I Alvarez, Julio G Prieto, et al.
Nature Reviews. Drug Discovery|June 27, 2015
SLC transporters as therapeutic targets: emerging opportunitiesLawrence Lin, Sook Wah Yee, Richard B Kim, et al.
The Oncologist|February 15, 2005
Cancer pharmacogenomics: powerful tools in cancer chemotherapy and drug developmentWooin Lee, A Craig Lockhart, Richard B Kim, et al.
Molecular Pharmaceutics|February 27, 2020
In Vitro Functional Characterization and in Silico Prediction of Rare Genetic Variation in the Bile Acid and Drug Transporter, Na<sup>+</sup>-Taurocholate Cotransporting Polypeptide (NTCP, <i>SLC10A1</i>)Laura E Russell, Yitian Zhou, Volker M Lauschke, et al.
Clinical and Translational Science|June 3, 2021
Pharmacogenomic-based personalized medicine: Multistakeholder perspectives on implementational drivers and barriers in the Canadian healthcare systemMathushan Subasri, David Barrett, Jovana Sibalija, et al.
Molecular Pharmacology|January 15, 2004
Identification of amino acids in rat pregnane X receptor that determine species-specific activationRommel G Tirona, Brenda F Leake, Larissa M Podust, et al.
Alimentary Pharmacology & Therapeutics|April 1, 2020
Letter: immunogenicity of infliximab-ready for routine prediction? Authors' replyAze Wilson, Celeste Peel, Qian Wang, et al.
Pageof 23

Showing results (61-70 of 226) with videos related to

Sort By:
Pageof 23
The Journal of Biological Chemistry|April 3, 2003
The human organic anion transport protein SLC21A6 is not sufficient for bilirubin transportPijun Wang, Richard B Kim, J Roy Chowdhury, et al.
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|June 13, 2013
Sildenafil and furosemide associated ototoxicity: consideration of drug-drug interactions, synergy, and broader clinical relevanceLeslie Skeith, Cory Yamashita, Sanjay Mehta, et al.
British Journal of Clinical Pharmacology|March 18, 2025
Severe myelosuppression and alopecia after thiopurine initiation in a patient with NUDT15 deficiencyAnnie Siyu Wu, Lee Mozessohn, Richard B Kim, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 20, 2002
The anthelminthic agent albendazole does not interact with p-glycoproteinGracia Merino, Ana I Alvarez, Julio G Prieto, et al.
Nature Reviews. Drug Discovery|June 27, 2015
SLC transporters as therapeutic targets: emerging opportunitiesLawrence Lin, Sook Wah Yee, Richard B Kim, et al.
The Oncologist|February 15, 2005
Cancer pharmacogenomics: powerful tools in cancer chemotherapy and drug developmentWooin Lee, A Craig Lockhart, Richard B Kim, et al.
Molecular Pharmaceutics|February 27, 2020
In Vitro Functional Characterization and in Silico Prediction of Rare Genetic Variation in the Bile Acid and Drug Transporter, Na<sup>+</sup>-Taurocholate Cotransporting Polypeptide (NTCP, <i>SLC10A1</i>)Laura E Russell, Yitian Zhou, Volker M Lauschke, et al.
Clinical and Translational Science|June 3, 2021
Pharmacogenomic-based personalized medicine: Multistakeholder perspectives on implementational drivers and barriers in the Canadian healthcare systemMathushan Subasri, David Barrett, Jovana Sibalija, et al.
Molecular Pharmacology|January 15, 2004
Identification of amino acids in rat pregnane X receptor that determine species-specific activationRommel G Tirona, Brenda F Leake, Larissa M Podust, et al.
Alimentary Pharmacology & Therapeutics|April 1, 2020
Letter: immunogenicity of infliximab-ready for routine prediction? Authors' replyAze Wilson, Celeste Peel, Qian Wang, et al.
Pageof 23